Rare and Neglected Diseases | Australian Biotech Company News

Home Tags Rare and Neglected Diseases

Biotechnology

Trial Triumphs, Takeover Talk Boost Reata Pharmaceuticals

BioChannel - February 10, 2020

Biotechnology

Gene Therapy Developer Passage Bio Files for $125M IPO

BioChannel - February 3, 2020

Biotechnology

AGTC Plans Pivotal Trial for XLRP Gene Therapy

BioChannel - January 9, 2020

Biotechnology

AGTC Grows Preclinical Pipeline with Gene Therapies for Congenital Hearing Loss,...

BioChannel - November 25, 2019

Biotechnology

Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership

BioChannel - November 21, 2019

Biotechnology

Alexion to Acquire Achillion for $930M+, Expanding Rare Disease Portfolio

BioChannel - October 16, 2019

Biotechnology

UCB to Acquire Ra Pharma for $2.1B, Raising Rare Disease Presence

BioChannel - October 10, 2019

Biotechnology

Deep Genomics Identifies AI-Discovered Candidate for Wilson Disease

BioChannel - September 25, 2019

Biotechnology

Sumitomo Dainippon Commits $3B toward Alliance with Roivant

BioChannel - September 6, 2019

Biotechnology

Acer Therapeutics Axes 60% of Workforce after FDA Rebuff

BioChannel - July 5, 2019

12 Page 1 of 2

Stay connected

Recent posts

ACM Prize in Computing awarded to AlphaGo developer

BioChannel - April 1, 2020

Update: AM-Pharma Increases Acute Kidney Injury Phase III Funds to €163M

BioChannel - March 31, 2020

Unlocking The Power Of Expert Analytics

BioChannel - March 31, 2020

Random article

ACM Prize in Computing awarded to AlphaGo developer

Update: AM-Pharma Increases Acute Kidney Injury Phase III Funds to €163M

Unlocking The Power Of Expert Analytics

Blood test detects wide range of cancers, available to at risk...